These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 3018566)

  • 1. Comparison of captopril and enalapril in patients with severe chronic heart failure.
    Packer M; Lee WH; Yushak M; Medina N
    N Engl J Med; 1986 Oct; 315(14):847-53. PubMed ID: 3018566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of captopril with enalapril in the therapy of heart failure: effect on hemodynamics and kidney function].
    Osterziel KJ; Dietz R; Mikulaschek K; Röhrig N; Schmid W; Manthey J; Kübler W
    Z Kardiol; 1988 Jun; 77(6):378-84. PubMed ID: 2850682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enalapril versus captopril in heart failure--effect on blood pressure and kidney function].
    Osterziel KJ; Dietz R
    Z Kardiol; 1991; 80 Suppl 2():28-34. PubMed ID: 2024541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [24-hour blood pressure and renal function in cardiac failure during the titration phase of captopril and enalapril].
    Osterziel KJ; Dietz R; Abushi A; Kübler W
    Z Kardiol; 1990 Nov; 79(11):742-7. PubMed ID: 2278166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of lisinopril and captopril in treatment of severe heart failure (NYHA III-IV) in high risk patients. Preliminary results of the trial].
    Risler T; Braun U; Klärner HG; Müller-Schauenburg W; Heitkamp HC; Brilla GG; Krämer BK; Seipel L
    Z Kardiol; 1991; 80 Suppl 2():40-3. PubMed ID: 1850942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of enalapril and captopril in the treatment of chronic heart failure].
    Tjon-A-Meeuw L; Hess OM; Greminger P; Maire R; Jenni R; Krayenbuehl HP
    Z Kardiol; 1990 Jun; 79(6):429-35. PubMed ID: 2198731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors in congestive heart failure.
    Deedwania PC
    Arch Intern Med; 1990 Sep; 150(9):1798-805. PubMed ID: 2132302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management.
    Packer M; Kessler PD; Gottlieb SS
    Postgrad Med J; 1986; 62 Suppl 1():179-82. PubMed ID: 3022272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of lisinopril and captopril in the treatment of left ventricular congestive heart failure--influence of duration of action on efficacy and safety.
    Giles TD
    Z Kardiol; 1991; 80 Suppl 2():35-9. PubMed ID: 1850941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.
    Packer M; Lee WH; Medina N; Yushak M; Kessler PD; Gottlieb SS
    Am J Med; 1987 Jun; 82(6):1119-26. PubMed ID: 3037896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Captopril and enalapril in the treatment of renal hypertension].
    Hasanagić H; Djukanović Lj; Subotić Z; Nesić V; Cavrić G
    Srp Arh Celok Lek; 1990; 118(7-8):285-90. PubMed ID: 2097777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
    Fettman MJ; Wilke WL; VanHouten DS; Hamar DW; Mikita DJ
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):131-46. PubMed ID: 2555851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Captopril versus digoxin in the treatment of mild to moderately severe heart failure].
    Heck I; Müller HM; Esser H; Lüderitz B
    Dtsch Med Wochenschr; 1989 May; 114(18):695-9. PubMed ID: 2653765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.